{"id":102519,"date":"2021-05-10T18:05:46","date_gmt":"2021-05-10T10:05:46","guid":{"rendered":"https:\/\/www.chinapulse.com\/?p=227614"},"modified":"2021-05-10T18:05:46","modified_gmt":"2021-05-10T10:05:46","slug":"covid-jab-maker-biontech-to-build-se-asia-manufacturing-site","status":"publish","type":"post","link":"https:\/\/www.chinalegalblog.com\/en\/2021\/05\/10\/covid-jab-maker-biontech-to-build-se-asia-manufacturing-site\/","title":{"rendered":"Covid jab maker BioNTech to build SE Asia manufacturing site"},"content":{"rendered":"<p>Covid jab maker BioNTech said Monday it would build a Southeast Asia headquarters and manufacturing site in Singapore to produce hundreds of millions of mRNA-based vaccines per year. Construction of the site will start this year, and it could become operational by 2023, the German company said in a statement.&#8230;<\/p>\n<p>This data comes from the <a href=\"https:\/\/www.chinapulse.com\/\" title=\"ChinaPulse.com provides Media Intelligence and Media Monitoring in China\" >ChinaPulse.com media intelligence and smart news insights monitoring platform<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Covid jab maker BioNTech said Monday it would build a Southeast Asia headquarters and manufacturing site in Singapore to produce hundreds of millions of mRNA-based vaccines per year. Construction of the site will start this year, and it could become op&#8230;<\/p>\n","protected":false},"author":250,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[213,1607,194,483,494,1542,484],"tags":[10323,10324,3942,1859,7035],"class_list":["post-102519","post","type-post","status-publish","format-standard","hentry","category-china-news","category-manufacturing","category-news-chinese-law","category-patent","category-pharmaceutical","category-technology","category-united-states","tag-coronavirus","tag-covid-19","tag-europe","tag-singapore","tag-vaccine"],"_links":{"self":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/102519","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/users\/250"}],"replies":[{"embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/comments?post=102519"}],"version-history":[{"count":2,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/102519\/revisions"}],"predecessor-version":[{"id":102521,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/102519\/revisions\/102521"}],"wp:attachment":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/media?parent=102519"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/categories?post=102519"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/tags?post=102519"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}